OSIR: Osiris Therapeutics, Inc. - Summary | Jitta

Osiris Therapeutics, Inc.

NASDAQ:OSIR

Notice
Stock data is unavailable or the company’s delisted.
Price
$18.99
Loss Chance
58.4%
4.25JITTA SCORE
56.96%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (0)
Recent Business Performance (0)
Financial Strength (50)
Return to Shareholders (0)
Competitive Advantage (19)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Revenue and EarningEarning loss detected in 2016
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
4.25
56.96%
2.21
135.20%
COMPANY DESCRIPTION
As of April 17, 2019, Osiris Therapeutics, Inc. operates as a subsidiary of Smith & Nephew plc.